Altamira Therapeutics (CYTO) Issues Year-End 2022 Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Altamira Therapeutics Provides Year-End 2022 Business Update
December 19, 2022 8:47 AM ESTHamilton, Bermuda, Dec. 19, 2022 (GLOBE NEWSWIRE) --
Altamira Therapeutics Provides Year-End 2022 Business Update
Strategic BentrioTM partnering or divestiture process enters decisive phasePartnering or divestiture process for inner ear therapeutics assets ongoingImplementing new organizational structure to support strategic focus on RNA businessPromoted Covadonga Pañeda, Ph.D., from Chief Development Officer to Chief Operating OfficerDatabase about to be locked in... More


